Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,400 | 865 | 3,484 | 11,427 | 27,266 |
| Marketable Securities | 4,000 | N/A | N/A | N/A | N/A |
| Receivables | 53 | N/A | N/A | N/A | 7 |
| TOTAL | $10,068 | $1,473 | $3,866 | $14,290 | $27,707 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 121 | 46 |
| Other Non-Current Assets | 0 | 0 | 1,101 | 347 | 478 |
| TOTAL | $N/A | $N/A | $1,101 | $469 | $524 |
| Total Assets | $10,068 | $1,473 | $4,966 | $14,758 | $28,231 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,559 | 1,356 | 1,476 | 1,124 | 948 |
| TOTAL | $1,786 | $1,684 | $1,798 | $1,596 | $1,445 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 152 | 300 |
| TOTAL | $N/A | $N/A | $N/A | $152 | $300 |
| Total Liabilities | $1,786 | $1,684 | $1,798 | $1,749 | $1,745 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,336 | 715 | 149 | 67 | 65 |
| Common Shares | 4 | 0 | 3 | 2 | 2 |
| Retained earnings | -226,629 | -216,786 | -206,218 | -185,563 | -171,274 |
| TOTAL | $8,281 | $-212 | $3,168 | $13,009 | $26,486 |
| Total Liabilities And Equity | $10,068 | $1,473 | $4,966 | $14,758 | $28,231 |